VanEck Pharmaceutical ETF
PPH
PPH
106 hedge funds and large institutions have $355M invested in VanEck Pharmaceutical ETF in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
48% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 40
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
106
Holding in Top 10
1
Calls
$5.35M
Puts
$1.02M
Top Buyers
| 1 | +$37.3M | |
| 2 | +$4.82M | |
| 3 | +$3.92M | |
| 4 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$3.23M |
| 5 |
WWM
WT Wealth Management
Scottsdale,
Arizona
|
+$2.51M |
Top Sellers
| 1 | -$148M | |
| 2 | -$30.9M | |
| 3 | -$19.6M | |
| 4 |
PCIA
Prime Capital Investment Advisors
Overland Park,
Kansas
|
-$11.8M |
| 5 |
LPL Financial
San Diego,
California
|
-$5.12M |